Cervical cancer is a malignant formation that occurs from the epithelial cells covering the cervix. About a third of the patients do not have children at the time of diagnosis. Therefore, organ-preserving technologies for the treatment of patients with cervical cancer are more than relevant.
Until recently At that time, women were offered only two solutions to the problem: radical surgery to remove the uterus and lymph nodes, or radiation therapy, which inevitably leads to a complete loss of reproductive function. Any of these methods does not leave young women with the opportunity to conceive, carry and give birth to a child.
In the earliest stages of the disease – in cancer in situ (translated from Latin. carcinoma in situ - "cancer in place"), when the process has not yet passed through the basement membrane (a thin cell-free layer separating connective tissue from the epithelium or endothelium), or has only slightly grown through the basement membrane (microinvasive cancer), in women who have not realized their reproductive function, the technology of choice may be knife conization of the cervix. This technique involves fragmentary removal of the affected area of the cervix using a scalpel.
If in No tumor cells will be detected in the removed fragment, in which case the patient will only need to undergo regular examinations by an oncogynecologist, and after a year, with normal test results and colposcopy data, the woman will be able to plan pregnancy.
For more in the later stages, organ-preserving surgery is possible - radical trachylectomy. This is an inherently unique operation that allows, without reducing the chances of a cure, compared with a radical removal operation, to preserve the uterus and ovaries.
Thanks to the organ-preserving operations in the world have already produced more than a hundred healthy children from women with a disease that was previously considered a verdict and left no chance for childbirth.
Was this information helpful?
Questions and answers
Ask a Question
.webp)
.webp)
.webp)
